ARBAN Act 2025: Will Congress Finally Ban All Asbestos in America?

While 67–70 countries have already banned all forms of asbestos [2], the United States continues to allow six types of asbestos in commercial products. The EPA's 2024 chrysotile asbestos ban addressed only one type and phases out over 12 years [1]—but Congress is considering more aggressive legislation. The Alan Reinstein Ban Asbestos Now (ARBAN) Act, named after a mesothelioma victim, seeks to eliminate all asbestos immediately [3], finally bringing the US into alignment with international public health standards.

What Is the ARBAN Act and Why Was It Introduced in Congress?

The Alan Reinstein Ban Asbestos Now (ARBAN) Act is proposed federal legislation designed to accomplish what the EPA's phased approach cannot: an immediate, comprehensive elimination of the substance from American commerce [3]. Named after mesothelioma victim Alan Reinstein, whose advocacy championed stronger protections before his death, the Act directly addresses a critical public health gap.

Unlike the EPA's regulatory authority—which is limited to individual chemicals or substances [1]—Congressional legislation can impose sweeping, immediate bans. The ARBAN Act would prohibit the manufacture, import, processing, distribution, and sale of all six fiber types [5], with no phase-out period and no exemptions for "safe use" claims.

"The United States has a moral obligation to adopt comprehensive protections equivalent to those in other developed nations. When 67 countries have already eliminated the substance entirely, allowing six types to remain legal creates an indefensible gap in our public health infrastructure. ARBAN addresses this gap directly and immediately."

— Paul Danziger, Founding Partner, Danziger & De Llano

Why Now?

Several factors have converged to make comprehensive legislation targeting the mineral more viable in 2025–2026:

• Global consensus: With 67–70 nations implementing comprehensive bans [2], the US looks increasingly isolated. Continued use of the substance undermines America's public health credibility internationally.
• Ongoing mesothelioma epidemic: An estimated 3,000+ new mesothelioma cases are diagnosed in the US annually [6], with most resulting from decades-old exposures. The disease continues to claim lives at rates comparable to other developed nations where the fiber is banned.
• EPA's limitations: The agency's 2024 chrysotile ban, while meaningful, highlighted the constraints of regulatory approaches [1]. A ban on one fiber type while five remain legal is seen as insufficient by many advocates.
• Corporate accountability pressure: As bankruptcy trusts face depletion and defendants face ongoing litigation costs, comprehensive legislation becomes attractive as a pathway to finality and cost certainty.
• Bipartisan disease focus: Mesothelioma affects both blue-collar workers and suburban residents; military veterans and civilians; Republicans and Democrats. The disease transcends traditional political divisions.

How Does the ARBAN Act Compare to the 2024 EPA Chrysotile Ban?

Understanding the difference between legislative and regulatory approaches is critical for mesothelioma victims. Both approaches aim to reduce exposure to the substance, but they operate differently and protect differently.

Why Both Bans Matter

The EPA's 2024 chrysotile ban is important because chrysotile represents approximately 95% of all such fiber imported into the United States [4]. Eliminating this type addresses the majority of ongoing exposure risk. However, the remaining five types are equally carcinogenic and equally capable of causing mesothelioma [5]. The ARBAN Act acknowledges that partial protection is incomplete protection.

"A 12-year phase-out that allows five fiber types to remain legal is progress, but it's not sufficient. Workers exposed to amosite or crocidolite during that 12-year window face the same mesothelioma risks. Comprehensive legislation provides the certainty that manufacturers and workers deserve."

— Paul Danziger, Founding Partner, Danziger & De Llano

Why Are 67–70 Countries Ahead of the United States on Asbestos Bans?

The global movement to ban the mineral began in the 1970s with Scandinavian countries recognizing mesothelioma's catastrophic toll [2]. Canada banned the substance in 2018; the European Union in 2005; Australia in 2003 [2]. Yet the United States, despite having one of the world's largest asbestos litigation systems and the most extensive medical research infrastructure, has lagged behind.

Historical and Political Factors

• Industry lobbying: Domestic manufacturers and companies using the fiber in products have consistently lobbied against comprehensive bans, arguing for "safe use" standards instead [7].
• Regulatory fragmentation: The EPA operates within the Toxic Substances Control Act (TSCA), which requires risk assessment and feasibility analysis [1]. Legislative bans can operate differently, based on public health principles rather than cost-benefit analyses.
• Litigation vs. legislation: The US mesothelioma litigation system creates compensation through lawsuits and bankruptcy trusts, which may reduce political pressure for prevention. Other nations prioritized prevention rather than litigation-based compensation.
• Fiber exportation: The US has historically exported these materials to developing nations, creating pressure to maintain domestic industries built around the mineral. International bans reduced this market, but domestic industries persisted.

The result is that corporate coverups and ongoing exposures continue in the US while global best practices have moved decisively toward comprehensive elimination.

Which Asbestos Types Are Still Legal in the United States?

Understanding all six fiber types is essential for workers and their families, because each one poses mesothelioma risks [5]. The EPA's 2024 chrysotile ban addresses only one:

The Six Asbestos Types

• Chrysotile: The most commonly used type (95% of US imports) [4]. Found in insulation, brake linings, roofing, gaskets, and countless industrial products. Subject to EPA's 2024 ban but with 12-year phase-out.
• Amosite: "Brown asbestos." Used in insulation, ceiling tiles, and industrial products. Still legal in the US. Equally carcinogenic as chrysotile.
• Crocidolite: "Blue asbestos." Historically used in pipe insulation and fireproofing. Still legal in the US. One of the most potent mesothelioma-causing fiber types [5].
• Tremolite: Typically used as contamination in talc products and certain mineral ore. Still legal in the US in specific applications.
• Anthophyllite: Rare in commercial applications but used in some industrial insulation and ACM products. Still legal in the US.
• Actinolite: Similar to tremolite; used primarily as contamination in talc and mineral products. Still legal in the US.

The ARBAN Act would eliminate all six types immediately, leaving no legal products containing the mineral in US commerce.

What Products Still Contain Legal Asbestos?

Despite decades of litigation and growing awareness of mesothelioma risks, multiple ACM (asbestos-containing material) products remain legal and in use [1]:

• Gaskets and packings: Industrial equipment seals
• Insulation materials: Pipe insulation, block insulation, sprayed insulation (some restricted but not banned)
• Roofing materials: Fiber-cement shingles, roofing tar
• Electrical components: Wire insulation, switchgear
• Brake linings and clutch plates: Automotive applications
• Talc products: Often contaminated with tremolite or actinolite
• Imported products: Products manufactured overseas with the fiber, then imported into the US

For workers in manufacturing, automotive repair, building maintenance, and renovation, exposure to these products remains a present-day risk, not a historical issue [6] [7].

How Would ARBAN Legislation Impact Mesothelioma Victims and Their Families?

While ARBAN would not directly provide compensation to existing mesothelioma victims, it would significantly strengthen the legal and settlement environment for ongoing cases [3].

Direct Litigation Benefits

• Elimination of "safe use" arguments: Once Congress declares the substance illegal in all forms, defendants cannot argue that products containing the fiber were "safely manufactured" or that exposure was acceptable. This strengthens settlement pressure.
• Increased corporate accountability: A comprehensive ban signals Congressional consensus that the mineral poses unacceptable risks. This shifts the litigation narrative away from isolated cases and toward systemic liability.
• Bankruptcy trust prioritization: Companies with active trust funds would face pressure to provide generous settlement terms once all forms of the substance are illegal, eliminating arguments for conservative trust distributions.
• Venue advantages: Juries in states with comprehensive fiber protection laws view defendants less favorably than juries in states that still allow the substance. Federal legislation would create uniform, nationwide protection.

Long-Term Prevention

For families of future mesothelioma victims, ARBAN would provide the most important benefit: prevention. Workers and their families would be protected from occupational and environmental fiber exposure [6], reducing future disease incidence.

"When Congress bans the substance in all its forms, it sends a powerful message: this nation will no longer tolerate preventable mesothelioma. That message strengthens existing cases by eliminating every argument defendants use to minimize liability. It also protects the next generation from the same tragedy."

— Paul Danziger, Founding Partner, Danziger & De Llano

What Is the Likelihood That Congress Will Pass ARBAN?

Predicting Congressional action is always uncertain, but several factors suggest meaningful momentum:

• Bipartisan support: Mesothelioma affects workers regardless of political party. Both Republican and Democratic constituencies include exposure victims and occupational safety advocates.
• International pressure: As more nations adopt comprehensive bans [2], the US isolation becomes more politically costly. International commerce and reputation create incentives to harmonize standards.
• Legal precedent: The EPA's 2024 chrysotile ban provides proof that comprehensive restrictions on the mineral are legally and scientifically defensible [1], reducing industry arguments about feasibility.
• Economic efficiency: A single Congressional ban may be more efficient for manufacturers than navigating state-by-state regulations. Some industries may support uniform federal standards.

However, Congressional timelines are unpredictable [3], and industry opposition remains real. Mesothelioma victims and their families should not wait for ARBAN to become law before pursuing compensation. Existing lawsuits and trust fund claims are available now and should be pursued immediately.

How Can Mesothelioma Victims Access Compensation Today?

While the ARBAN Act represents important future protection, victims diagnosed today need immediate compensation. Multiple pathways exist, and experienced attorneys can help navigate all of them simultaneously.

Asbestos Litigation

Occupational exposure to the fiber creates clear legal liability. Companies that manufactured, distributed, or used ACM products without adequate warnings can be held responsible for resulting mesothelioma. Settlements average $1–2 million, with trial verdicts frequently exceeding $5 million [4].

Asbestos Trust Funds

More than 60 companies have established bankruptcy trusts holding over $30 billion for mesothelioma victims [4]. These funds operate independently of litigation and often provide rapid compensation. Experienced attorneys can file trust claims simultaneously with lawsuits, maximizing total recovery.

Veterans Benefits

Military veterans exposed to the mineral during service can access VA benefits, including disability compensation and healthcare. These benefits operate separately from litigation and can be combined with lawsuit settlements.

Our mesothelioma lawyers can evaluate your exposure history and identify all applicable compensation sources. We pursue lawsuits, trust fund claims, and veteran benefits simultaneously to maximize your family's recovery.

Frequently Asked Questions About the ARBAN Act

Take Action Now—Don't Wait for Legislation

The ARBAN Act represents important future protection and will strengthen mesothelioma lawsuits if it passes [3]. However, Congressional timelines are uncertain, and mesothelioma victims cannot afford to wait. Every day of delay reduces the time available to pursue compensation and allows defendants to develop case strategies.

A free case assessment can identify your compensation options, determine which asbestos trusts apply to your exposure, and estimate your settlement range. This information is crucial for making decisions about your family's financial future.

Related Resources

• EPA Chrysotile Asbestos Ban 2024: What It Means for Mesothelioma Cases — Understand the EPA's regulatory approach
• Asbestos Trust Funds: Complete Compensation Guide — Learn how to maximize trust fund claims
• Find Mesothelioma Lawyers by State — Connect with experienced specialists
• Free Case Assessment — Evaluate your compensation options

Learn More About Asbestos Legislation and History

• Asbestos History Timeline — From ancient use to modern regulation
• Corporate Asbestos Coverup — How manufacturers hid asbestos dangers
• EPA Asbestos Regulations — Current regulatory status and policy

---

Sources:

1. [1] US Environmental Protection Agency — Final Rule on Asbestos (2024)
2. [2] International Ban Asbestos Secretariat — Global Asbestos Ban Timeline (2025)
3. [3] US Congress — ARBAN Act Legislation Status (2025)
4. [4] US Geological Survey — Asbestos Production, Imports, and Exports (2024)
5. [5] Agency for Toxic Substances and Disease Registry — Asbestos Toxicological Profile (2024)
6. [6] CDC/NIOSH — Asbestos Exposure and Health Effects (2024)
7. [7] National Environmental Health Association — Occupational Asbestos Exposure Standards, Journal of Environmental Health (2023)

Last updated: February 18, 2026